
ImpediMed
Developing medical devices employing bioimpedance spectroscopy technologies.
Market cap
$53.8m
Enterprise value
$43m
Share price
AUD0.04 IPD.AX
Company register number
89705144
Authorizing premium user...
Developing medical devices employing bioimpedance spectroscopy technologies.